Resources
The latest in cell & gene research, from advanced therapies through to the latest developments in cell & gene research, therapies & manufacturing
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Cell & Gene Therapy Manufacturing
AAV Manufacturing Using Osmolality
New Data from the Cell and Gene Therapy Catapult shows improved yield, quality, and process efficiency for AAV manufacturing using osmolality.
Stem Cell Development & Manufacturing
Beating the System with Advanced High Throughput and Real-Time Analytics for Biopharmaceutical Manufacturing
Can advanced analytical processing and real-time data monitoring conquer the complexity of Bio-pharmaceutical manufacturing? We ask Udayanath Aich, Director at Bristol Myers Squibb.
Upstream & Downstream Bioprocessing
Process Development and Manufacturing Avenues for Gene Therapy Vectors
Hemant Dhamne, Head of Process Development of Gene Therapy at King's College London, discusses the process of viral vector production, the current and future manufacturing technologies, and challenges in the field.
Cell & Gene Therapy Manufacturing
In Conversation With...Ruth Faram, HigherSteaks
Dr. Faram is co-founder and Chief Scientific Officer at HigherSteaks, where she leads the company strategy and research focus for the Stem Cell, Bioprocess, Differentiation and Biomaterial teams.
Upstream & Downstream Bioprocessing
Novel Technologies Advancing Downstream Bioprocessing
Tuhina Bhattacharya, Associate Director of CMC Biologics at Corbus Pharmaceuticals, leads a Discussion Group on the future of downstream bioprocessing technologies.
Cell Therapy Development
In Conversation With Pedro Caetano Pinto, Lab Lead in Experimental Urology, Universität Greifswald
We interview Pedro-Caetano Pinto, Lab Head at the University of Greifswald to learn more about his work with microphysiological systems for advanced kidney and prostate cancer research.
Cell Therapy Development
Q and A with Vasiliki E. Kalodimou
Vasiliki Kalodimou of the NCSR DEMOKRITOS, discusses her work in cell therapy analytics, ahead of Oxford Global's Cell Therapy Analytics Event.
Stem Cell Development & Manufacturing
Combinatorial Culture Technology for Stem Cell Therapy Applications
How can combinatorial screening of diverse variables in process development optimise cell and gene therapies? Marina Tarunina, Research Director at Plasticell, investigates.
Tissue Engineering & 3D Models
Human Stem Cell Model Development for Neurodegenerative Diseases
How can the use of human stem cell models of neurodegenerative disease advance drug discovery? Clare Jones, Chief Scientific Officer at Talisman Therapeutics, investigates.
Cell & Gene Therapy Manufacturing
In Conversation With Jenny Prange, Head of GMP Production, Chief Scientific Officer and Co-Founder of Muvon Therapeutics
The present and the future, key insights into the cell and gene therapy manufacturing space
Gene Therapy Development
Abundant Stochastic Off-Target Activity by Base Editors
Can complementary approaches for off-target quantification demonstrate substantial levels in various state-of-the-art editors?
Gene Therapy Development
When to Cut and When to Inhibit? A Low-Throughput, Hands-On Investigation Of CRISPR-Cut and CRISPRi Efficiencies In iPSC And Neural Cells
Gene knockdown – the manual reduction of a particular gene's expression in target cells – entails the modification of cellular development in young cells. CRISPR gene editing techniques enable researchers such as Pia Johansson to induce gene knockdown in target cells.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things cell & gene